Patrick N. Harter

Professor for molecular Neuropathology

Ludwig Maximilian University of Munich

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Patrick N. Harter is a Professor of Molecular Neuropathology at Ludwig Maximilian University of Munich, Germany. His research focuses on glioblastoma, gangliogliomas, and the molecular mechanisms influencing tumor development and patient outcomes. Recent articles explore various aspects of these conditions, including survival probabilities, adverse clinical outcomes, and treatment effects in glioma patients.

Articles (7)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Michael W. Ronellenfitsch

GERMANY

View details

Ulrich Schüller

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Pia Susan Zeiner

Goethe University Frankfurt

GERMANY

View details

Martin Voss

University Hospital Frankfurt

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick N. Harter

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation

Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes

Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes

Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With Glioma

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

TGF‐β activates pericytes via induction of the epithelial‐to‐mesenchymal transition protein SLUG in glioblastoma

Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors

Collaborators (4)

Michael W. Ronellenfitsch

Ulrich Schüller

Pia Susan Zeiner

Martin Voss

Make your next move.